This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

GLP-1 receptor agonists and SGLT-2 inhibitors reduce COPD exacerbations among diabetes patients

GLP-1 receptor agonists and SGLT-2 inhibitors reduce COPD exacerbations among diabetes patients

Canada: A recent study published in the BMJ has highlighted that glucagon-like peptide 1 (GLP-1) receptor agonists, and sodium-glucose...
View All

Latest News and Guidelines

Subcutaneous semaglutide beneficial in weight loss management says JAMA

Subcutaneous semaglutide beneficial in weight loss management says JAMA

Maternal diabetes tied to poor blood sugar control and complications among youth with type 2 diabetes

Maternal diabetes tied to poor blood sugar control and complications among youth with type 2...

Obesity at MS diagnosis linked to higher current and subsequent levels of disability

Obesity at MS diagnosis linked to higher current and subsequent levels of disability

Overviewing Cardiac Safety Profile of Vildagliptin 100mg SR -ft-Prof. Dr Aravinda Jagadeesha

Overviewing Cardiac Safety Profile of Vildagliptin 100mg SR -ft-Prof. Dr Aravinda Jagadeesha

Microvascular complications of diabetes linked to pancreatic cancer

Microvascular complications of diabetes linked to pancreatic cancer

Trouble sleeping? You could be at risk of type 2 diabetes

Trouble sleeping? You could be at risk of type 2 diabetes

View All
X